2022 Continuing Education Credits

Registrants are responsible for confirming that credits earned will be accepted for their specified certification by the appropriate accrediting body.

Attendance at conference events will be verified electronically. Each attendee seeking continuing education credits/hours will need to complete an evaluation for each session attended. Your login credentials will be used to track and tabulate each attendee’s continuing education credits/hours. After the conference, certificates documenting attendance and the number of continuing education credits/hours earned will be electronically generated and emailed to all eligible attendees. Questions concerning Continuing Education Credits may be directed to meetings@aatod.org.

To access your credits, click here.

CONTINUING EDUCATION HOURS OFFE RED For a complete listing of hours offered, click here.

2022 CONTINUING EDUCATION HOURS (CEH) CREDIT

ASWB-AATOD, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB), www.aswb.org, through the Approved Continuing Education (ACE) program. The American Association for the Treatment of Opioid Dependence (AATOD) maintains responsibility for the program. ASWB Approval Period: 6/12/2022-6/12/2025. Social workers should contact their regulatory board to determine course approval. Social workers participating in this course will receive up to 34.5 (clinical or social work ethics) continuing education clock hours. Please view the Conference Program for more information on specific learning outcomes and objectives, the target audience and the number of credit hours awarded for all conference sessions from ASWB. NAADAC-AATOD is an approved single event provider with

NAADAC, provider number 62794, offering credits for counselors. NAADAC provider status expires on January 31, 2024 for the AATOD 2022 Conference for up to 34.5 CE Credits.

ADACBGA – AATOD is an approved provider with the Alcohol & Drug Abuse Certification Board of Georgia (IC&RC Affiliate), provider number 2022-09-003, offering credits for counselors.

2022 CONTINUING NURSING EDUCATION (CNE) CREDIT NEMSD-This continuing nursing education activity was approved by the Northeast Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

NEMSD Approver Unit has Approved Continuing Nursing Education Activity, AATOD 2022 Conference for October 30- November 3, 2022, for 34.5 Contact Hours. 2022 CONTINUING MEDICAL EDUCATION (CME) CREDIT AMA Credit Designation Statement:
The American Society of Addiction Medicine designates this live activity for a maximum of 33.50 AMA PRA

Category 1 Credit (s) rM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Society of Addiction Medicine (ASAM) and the American Association for the Treatment of Opioid Dependence, Inc. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians. Disclosure Information
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. These policies include mitigating all relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CE Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

 

CME Committee Reviewer
Catharina Armstrong, MD, FASAM – No relevant financial disclosures
Cara A. Poland, MD, MEd, DFASAM – No relevant financial disclosures
R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM – No relevant financial disclosures
Herbert L. Malinoff, MD, FACP, DFASAM – No relevant financial disclosures
Noel llogu, MD, MRCP, FASAM – No relevant financial disclosures Presenters
Aaron Greenblatt, MD – No relevant financial disclosures
Adam Lewis, JD – No relevant financial disclosures
Aditi Ringwala, MD – No relevant financial disclosures
Alain Litwin, MD, MPH – No relevant financial disclosures
Alan Nolan, LCSW – No relevant financial disclosures
Allison Thomson, MPH – No relevant financial disclosures
Ally Lor, RN, CARN – No relevant financial disclosures
Andre Jean Remy, MD – No relevant financial disclosures
Andrea Walker, MA, MPH – No relevant financial disclosures
Andrew Schreier, ICS – No relevant financial disclosures
Andrew Stone, MD – No relevant financial disclosures
Andrew Talal, MD, MPH – No relevant financial disclosures
Anita Kennedy, BS CRPA CMA – No relevant financial disclosures
Anna Stewart, MBA- No relevant financial disclosures
Annabelle (Mimi) Belcher, PhD – No relevant financial disclosures
Anne Ruble, MD, MPH – No relevant financial disclosures
Anthony Folland, BA- No relevant financial disclosures
Arthur McFarlane, MS – No relevant financial disclosures
Ashton Marra, MS – No relevant financial disclosures
Babak lmanoel, DO- No relevant financial disclosures
Beth Rutkowski, MPH – No relevant financial disclosures
Brandee Izquierdo, DPA, MPA, CPRS – No relevant financial disclosures
Brenda Davis, MSW, CASAC-T, CMA – No relevant financial disclosures
Brian Myers, MBA, MTS, CMPE – No relevant financial disclosures
Brittania Liebla, DNP – No relevant financial disclosures
Carla Carter, JD – No relevant financial disclosures
Casey Tiefenwerth, MSW – No relevant financial disclosures
Catherine Abrams, LMSW, CAC-AD, RPS – No relevant financial disclosures Charissa Patricelli, MD – No relevant financial disclosures
Chrissie Martin, LMFT, LACS, CS – No relevant financial disclosures
Christina Mazza, RPS, CPRS, CCHW – No relevant financial disclosures Christine Neeb, MD – No relevant financial disclosures
Christine Scalise, MA, LPG, LCADC – No relevant financial disclosures Colleen Flanigan, RN, MS – No relevant financial disclosures
Dana Heilman, BS, MSW, MPH – No relevant financial disclosures
Daniel Barden, MS – No relevant financial disclosures
Darren McGregor, MS, MHS, LCMFT – No relevant financial disclosures David Whitesock – Does Disclose Commonly Well (Salary/Stockholder)
Deborah Reid, JD – No relevant financial disclosures
Deena Murphy, PhD – No relevant financial disclosures
Desmond Haneef – Perry, PRS – No relevant financial disclosures
Dona Dmitrovic, MHS – No relevant financial disclosures
Ed Soffe, LCSW-C – No relevant financial disclosures
Edward Long, AB, MA, PhD – No relevant financial disclosures
Elizabeth Connolly, MPA – No relevant financial disclosures
Ellen Weber, JD – No relevant financial disclosures
Emily Hosea – No relevant financial disclosures
Eric Schwartz, MD, MBA – No relevant financial disclosures
Eric Weintraub, MD – No relevant financial disclosures
Ericka Stropka, BS – No relevant financial disclosures
Faye Taxman, PhD – No relevant financial disclosures
Filippo Della Rocca – No relevant financial disclosures
Frances McGaffey, MPP – No relevant financial disclosures
G. Malik Burnett, MD, MBA, MPH – No relevant financial disclosures
Gabrielle de la Gueronniere, JD – No relevant financial disclosures
Gina Zaccagnino, LCSW – No relevant financial disclosures
Gregory Branch, MD, MBA, CPE – No relevant financial disclosures
Heather Raley, LCPC – No relevant financial disclosures
Hedi Levine, PhD – No relevant financial disclosures
Holly Hagle, PhD – No relevant financial disclosures
James Anderson, PA-C – No relevant financial disclosures
James Yoe, PhD – No relevant financial disclosures
Jason Kletter – Does Disclose BayMark Health Services (Employment) Salary
Jeffrey Hsu, MD – No relevant financial disclosures
Jessica Blose, LMHC, SUDP, NCC, CCMHC – No relevant financial disclosures John Brooklyn, MD – No relevant financial disclosures
John Hamilton, LMFT, LADC – No relevant financial disclosures
John McCarthy, MD – No relevant financial disclosures
Jonathan Stoltman, PhD – No relevant financial disclosures
Joshua Nirella, MS – No relevant financial relationships
Julie Achtyl, MS, LMHC, Master CASAC, NCC, ACS – No relevant financial disclosures Justin Berk, MD, MPH, MBA – No relevant financial disclosures
Kate Dunn, MSN, RN, CNL – No relevant financial disclosures
Katherine Findley, PhD, MSW – No relevant financial disclosures
Kathleen Rebbert-Franklin, LCSW-C – No relevant financial disclosures
Kathryn Cates-Wessel – No relevant financial disclosures
Katie Rouse, BA – No relevant financial disclosures
Kelly Coble, LCSW-C – No relevant financial disclosures
Kenneth Stoller – Does Disclose Berkshire Biomedical LLC (Consulting)
Kenny House, LCAS, CCS – No relevant financial disclosures
Kirsten Forseth, MPH – No relevant financial disclosures
Kisha Winston-Watkins, MBA, LCSW-C – No relevant financial disclosures
Kristi O’Malley, JD – No relevant financial disclosures
Krysten Garcia, BA – No relevant financial disclosures
Larry Onate, MD – No relevant financial disclosures
Latonya Adjei-Tabi, MPA – No relevant financial disclosures
Laura Maroldo – Does Disclose- AbbVie (Consulting) & Gilead (Speakers Bureau)
Laurie Krom, MS – No relevant financial disclosures
Linda Hurley, MA – No relevant financial disclosures
Lori Canane, LADC II – No relevant financial disclosures
Marc Fishman – Does Disclose Alkermes (Consulting) (Products/Services: Extended-release naltrexone) (Consulting Fees (e.g., advisory boards), research grant) Drug Delivery LLC (Consulting) (Products/Services: naltrexone implant) (Consulting Fees (e.g., advisory boards)
Margaret Marcello, BSN, RN, PMH-BC – No relevant financial disclosures
Maria Bruni, PhD – No relevant financial disclosures
Marian Currens, CRNP – No relevant financial disclosures
Marie Stratton, CHRS – No relevant financial disclosures
Mark Kraus, MD – No relevant financial disclosures
Mark Parrino, MPA – No relevant financial disclosures
Marla Oros, RN, MS, FAAN – No relevant financial disclosures
Mary Ann Thompson – No relevant financial disclosures
Mary Keller, MA – No relevant financial disclosures
Matthew Burgan, MD – No relevant financial disclosures
Maureen O’Neill Biggs, MSW, LCSW – No relevant financial disclosures
Meaghan Elliott, BS – No relevant financial disclosures
Megan Marx, MPA, NCPRSS – No relevant financial disclosures
Michael Gordon – Does Disclose Alkermes (Other Activities) (Products/Services: Study drug (VIVITROL) donation for NIDA/NIH study)
(Honoraria, Study drug) Braeburn (Other Activities) (Products/Services: study drug (BRIXADI/BUVADIL) for NIH/NIDA funded study) (Honoraria, Study drug) MedicaSafe (Other Activities) (Products/Services: Medication dispensing device for NIH/NIDA funded study) (Honoraria, medication dispensing device)
Michael Kidorf, PhD – No relevant financial disclosures
Michael Litterer, CHES, CPS, FHELA – No relevant financial disclosures
Michael Miller – Does Disclose US WorldMeds (Consulting) (Consulting Fees (e.g., advisory boards)
Michelle Byron, LPN – No relevant financial disclosures
Michelle Lalinde – No relevant financial disclosures
Michelle Marshall – No relevant financial disclosures
Miriam Delphin-Rittmon, PhD – No relevant financial disclosures
Mishka Terplan, MD – No relevant financial disclosures
Monica White, MS, CAC-AD, RPS – No relevant financial disclosures
Nancy Young, PhD – No relevant financial disclosures
Nicholas Van Dyke – Does Disclose BayMark Health Services (Employment)(Products/Services: Employee of company) (Salary) Nicole Augustine, MPH, MCHES, PS – No relevant financial disclosures
Patricia Precin, PhD – No relevant financial disclosures
Patti Juliana, PhD – No relevant financial disclosures
Rahul Gupta, MD, MPH, MBA, FACP – No relevant financial disclosures
Rebecca Trott, LCSW-C – No relevant financial disclosures
Rebekah Joab, JD – No relevant financial disclosures
Regina Gullette, PhD, LICDC-CS, MAC, SAP – No relevant financial disclosures
Robert Kent, JD – No relevant financial disclosures
Robin Rickard, JD – No relevant financial disclosures
Rosemarie Martin, PhD – No relevant financial disclosures
Ryan Mueller, MEd, LPC, LAC – No relevant financial disclosures
Sadie Smith, MSW – No relevant financial disclosures
Salima Montes, LCPC, CAC-AD – No relevant financial disclosures
Sara Gefvert, CRS/CPS, CMA – No relevant financial disclosures
Sarah Sweeney, MSW, MPH – No relevant financial disclosures
Shani Litwin, BA – No relevant financial disclosures
Sharif Nankoe, MD, MPA, MA, FASAM – No relevant financial disclosures
Sika Yeboah-Sampang, JD – No relevant financial disclosures
Steve Millette, MS – No relevant financial disclosures
Susan Hadley, MD – No relevant financial disclosures
Suzanne Borys, EdD – No relevant financial disclosures
Tara Kunkel, MSW – No relevant financial disclosures
Teri Morgan-Urie, CADCII – No relevant financial disclosures
Theresa Tassey, MD, MPH, MS – No relevant financial disclosures
Tina Masai – No relevant financial disclosures
Tracy Agee, NP – No relevant financial disclosures
Tracy Desruisseaux, LADC-1 – No relevant financial disclosures
Tracy Schulden, LCSW-C – No relevant financial disclosures
Tyrell Moyd, RPS, RCP- No relevant financial disclosures
Vanessa Baaklini, MSW – No relevant financial disclosures
Vickie Walters, LCSW-C – No relevant financial disclosures
Vinay Parekh, MD – No relevant financial disclosures
Yehoshua Mirkin – No relevant financial disclosures
Yngvild Olsen, MD, MPH – No relevant financial disclosures

Planning Committee
Kenneth Stoller, MD – Does disclose Berkshire Biomedical LLC (Consultant)
Susan A. Storti, PhD, RN, NEA-BC, CARN-AP – No relevant financial disclosures Holly Broce, MHA, LCADC – No relevant financial disclosures
Antoinette (Toni) Maynard-Carter – No relevant financial disclosures
Michael Rizzi – No relevant financial disclosures
Vickie L. Walters, LCSW-C – No relevant financial disclosures
Marian Currens CRNP Director – No relevant financial disclosures
Lillian Dannard, LCSW-C – No relevant financial disclosures
Robert C. Lambert, MA – No relevant financial disclosures
Barry Page – No relevant financial disclosures
Maria Ramos, CMP – No relevant financial disclosures
Brent Schwartz – No relevant financial disclosures
Tomell Harbison – No relevant financial disclosures
Mark W. Parrino, MPA – No relevant financial disclosures
Carleen Maxwell-Taylor – No relevant financial disclosures
Angelina Budija – No relevant financial disclosures
Sabrina Jones – No relevant financial disclosures

Visit the aatod conference website for more details…www.aatodconference.com.

@aatod1984
  • Welcome to the #aatod2024 Conference
  • Welcome to Las Vegas. We invite you to attend this evening’s AATOD Board meeting ➡️ bit.ly/4apbmVt #aatod2024
  • Join us for the highly acclaimed 8-hour clinician’s course which convenes on Sunday, May 19, 2024 ➡️ bit.ly/3UOKtVi
#aatod2024
  • 📰 AATOD Unites Global Leaders in Opioid Use Disorder Treatment for Pivotal Las Vegas Summit 
➡️https://prn.to/3wEvR2G #OUD #somuchmorethanmedication #aatod2024
  • 💻 Welcome Message from Dr. Dinita Smith, Psy.D, MSW - #aatod2024 Conference Chair 

Thank you to our generous Conference Sponsors, Hosts, Exhibitors, Keynote Speakers, Presenters, Volunteers, and the entire Conference Planning Committee.

Online registration is still available. We look forward to welcoming you to Las Vegas!
  • Post & Hashtag 📸 
We would love to hear about your #aatod2024 conference experience on social media.
  • Conference Program Spotlight - Exhibits
The #aatod2024 Conference will attract over 1,600 physicians, social workers, nurses, counselors, program administrators, executive directors, and other treatment providers from many countries. Visit the AATOD Exhibit Hall for networking opportunities, to learn about new products & services and for guidance on how to improve patient treatment ➡️ bit.ly/3yi8T1M.
  • May 7, 2024 = #NationalFentanylAwarenessDay #JustSayKNOW
➡️ fentanylawarenessday.org

As many of you know, the #aatod2024 Conference is just one week away. Our impressive conference program consists of 2 Pre-Conference sessions, 4 Poster Author sessions and 1 Hot Topic Roundtable addressing the urgent problem of illicit fentanyl. These educational sessions are open to all conference attendees. 

Please visit our conference program for more details ➡️ bit.ly/3Ue57Q6
  • You won’t want to miss these 3 POWERFUL Plenary Sessions ready to set the stage in Las Vegas less than 2 weeks. Register today for the #aatod2024 Conference, the world's premier training conference event for the Treatment of Opioid Use Disorder ➡️www.aatodconference.com⬅️
  • 📣 Announcing the AMAZING Line-Up of Plenary Speakers

💻 View the #aatod2024 Conference Video Message from Ann Jamieson, MS,LADC/MH - AATOD’s Plenary Chair.

😊 We couldn’t be more excited about what we have in store for you next week in the spectacular city of Las Vegas where we will convene our conference!

🎤 You will not want to miss the three impressive plenary sessions that have been organized to deliver you extraordinary presentations for your educational purposes. These Plenary Sessions will cover a range of topics that highlight our conference theme, “Treating Opioid Use Disorder: So Much More Than Medication.” We have packed a lot of information into the plenary sessions and are excited to present the policies and strategies in Nevada and nationally.

Join us in Las Vegas by registering for the #aatod2024 Conference ➡️ www.aatodconference.com.
Welcome to the #aatod2024 Conference
1 week ago
View on Instagram |
1/10
Welcome to Las Vegas. We invite you to attend this evening’s AATOD Board meeting ➡️ bit.ly/4apbmVt #aatod2024
Welcome to Las Vegas. We invite you to attend this evening’s AATOD Board meeting ➡️ bit.ly/4apbmVt #aatod2024
1 week ago
View on Instagram |
2/10
Join us for the highly acclaimed 8-hour clinician’s course which convenes on Sunday, May 19, 2024 ➡️ bit.ly/3UOKtVi
#aatod2024
Join us for the highly acclaimed 8-hour clinician’s course which convenes on Sunday, May 19, 2024 ➡️ bit.ly/3UOKtVi #aatod2024
1 week ago
View on Instagram |
3/10
📰 AATOD Unites Global Leaders in Opioid Use Disorder Treatment for Pivotal Las Vegas Summit 
➡️https://prn.to/3wEvR2G #OUD #somuchmorethanmedication #aatod2024
📰 AATOD Unites Global Leaders in Opioid Use Disorder Treatment for Pivotal Las Vegas Summit ➡️https://prn.to/3wEvR2G #OUD #somuchmorethanmedication #aatod2024
2 weeks ago
View on Instagram |
4/10
💻 Welcome Message from Dr. Dinita Smith, Psy.D, MSW - #aatod2024 Conference Chair Thank you to our generous Conference Sponsors, Hosts, Exhibitors, Keynote Speakers, Presenters, Volunteers, and the entire Conference Planning Committee. Online registration is still available. We look forward to welcoming you to Las Vegas!
2 weeks ago
View on Instagram |
5/10
Post & Hashtag 📸 
We would love to hear about your #aatod2024 conference experience on social media.
Post & Hashtag 📸 We would love to hear about your #aatod2024 conference experience on social media.
2 weeks ago
View on Instagram |
6/10
Conference Program Spotlight - Exhibits
The #aatod2024 Conference will attract over 1,600 physicians, social workers, nurses, counselors, program administrators, executive directors, and other treatment providers from many countries. Visit the AATOD Exhibit Hall for networking opportunities, to learn about new products & services and for guidance on how to improve patient treatment ➡️ bit.ly/3yi8T1M.
Conference Program Spotlight - Exhibits The #aatod2024 Conference will attract over 1,600 physicians, social workers, nurses, counselors, program administrators, executive directors, and other treatment providers from many countries. Visit the AATOD Exhibit Hall for networking opportunities, to learn about new products & services and for guidance on how to improve patient treatment ➡️ bit.ly/3yi8T1M.
2 weeks ago
View on Instagram |
7/10
May 7, 2024 = #NationalFentanylAwarenessDay #JustSayKNOW
➡️ fentanylawarenessday.org

As many of you know, the #aatod2024 Conference is just one week away. Our impressive conference program consists of 2 Pre-Conference sessions, 4 Poster Author sessions and 1 Hot Topic Roundtable addressing the urgent problem of illicit fentanyl. These educational sessions are open to all conference attendees. 

Please visit our conference program for more details ➡️ bit.ly/3Ue57Q6
May 7, 2024 = #NationalFentanylAwarenessDay #JustSayKNOW ➡️ fentanylawarenessday.org As many of you know, the #aatod2024 Conference is just one week away. Our impressive conference program consists of 2 Pre-Conference sessions, 4 Poster Author sessions and 1 Hot Topic Roundtable addressing the urgent problem of illicit fentanyl. These educational sessions are open to all conference attendees. Please visit our conference program for more details ➡️ bit.ly/3Ue57Q6
2 weeks ago
View on Instagram |
8/10
You won’t want to miss these 3 POWERFUL Plenary Sessions ready to set the stage in Las Vegas less than 2 weeks. Register today for the #aatod2024 Conference, the world's premier training conference event for the Treatment of Opioid Use Disorder ➡️www.aatodconference.com⬅️
You won’t want to miss these 3 POWERFUL Plenary Sessions ready to set the stage in Las Vegas less than 2 weeks. Register today for the #aatod2024 Conference, the world's premier training conference event for the Treatment of Opioid Use Disorder ➡️www.aatodconference.com⬅️
You won’t want to miss these 3 POWERFUL Plenary Sessions ready to set the stage in Las Vegas less than 2 weeks. Register today for the #aatod2024 Conference, the world's premier training conference event for the Treatment of Opioid Use Disorder ➡️www.aatodconference.com⬅️
You won’t want to miss these 3 POWERFUL Plenary Sessions ready to set the stage in Las Vegas less than 2 weeks. Register today for the #aatod2024 Conference, the world's premier training conference event for the Treatment of Opioid Use Disorder ➡️www.aatodconference.com⬅️
3 weeks ago
View on Instagram |
9/10
📣 Announcing the AMAZING Line-Up of Plenary Speakers 💻 View the #aatod2024 Conference Video Message from Ann Jamieson, MS,LADC/MH - AATOD’s Plenary Chair. 😊 We couldn’t be more excited about what we have in store for you next week in the spectacular city of Las Vegas where we will convene our conference! 🎤 You will not want to miss the three impressive plenary sessions that have been organized to deliver you extraordinary presentations for your educational purposes. These Plenary Sessions will cover a range of topics that highlight our conference theme, “Treating Opioid Use Disorder: So Much More Than Medication.” We have packed a lot of information into the plenary sessions and are excited to present the policies and strategies in Nevada and nationally. Join us in Las Vegas by registering for the #aatod2024 Conference ➡️ www.aatodconference.com.
3 weeks ago
View on Instagram |
10/10

#aatod2024 Conference – Las Vegas

COUNTDOWN

2024 Conference

AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
RSS
Follow by Email
Facebook
Twitter
YouTube
LinkedIn
Instagram
Stay Connected to AATOD